Multiple sclerosis other imaging findings: Difference between revisions
mNo edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
there are enhanced [[lesions]] in double delayed high dose [[CT scan]] of [[MS]] [[patients]]. | |||
==Other imaging findings== | ==Other imaging findings== | ||
==== double delayed high dose CT scan: ==== | |||
In multiple sclerosis we have enhanced [[lesions]] in double delayed high dose [[CT scan]]. These lesions in DDHD [[CT scan]] are indicators of [[blood brain barrier]], so this method is useful in the [[acute]] phase of the disease. After [[steroid]] therapy in [[MS]] [[patients]] we can’t rely on DDHD [[CT scan]] anymore because [[steroid]] therapy will dramatically reduce this [[lesions]] on [[CT scan]]. | |||
==References== | ==References== |
Revision as of 13:16, 1 March 2018
Multiple sclerosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Multiple sclerosis other imaging findings On the Web |
American Roentgen Ray Society Images of Multiple sclerosis other imaging findings |
Risk calculators and risk factors for Multiple sclerosis other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
there are enhanced lesions in double delayed high dose CT scan of MS patients.
Other imaging findings
double delayed high dose CT scan:
In multiple sclerosis we have enhanced lesions in double delayed high dose CT scan. These lesions in DDHD CT scan are indicators of blood brain barrier, so this method is useful in the acute phase of the disease. After steroid therapy in MS patients we can’t rely on DDHD CT scan anymore because steroid therapy will dramatically reduce this lesions on CT scan.